BioMotiv
is the mission-aligned development company of The Harrington Project for Discovery and Development... Read moreBioMotiv
is the mission-aligned development company of The Harrington Project for Discovery and Development... Read more
CEO
Baiju R. Shah
News
Mar 17, 2021
DailyBusiness
BioMotiv: BioCity drugs developer secures 38m investment
Mar 17, 2021
FinSMEs
BioMotiv: Amphista Therapeutics Raises $53M in Series B Funding
Jan 05, 2021
BioSpace
BioMotiv: Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines
Jan 05, 2021
The Business Journals: Philadelphia
BioMotiv: Aro Biotherapeutics closes $88M investment round, plans to double staff
Apr 07, 2020
Crain's Cleveland Business
BioMotiv: BioMotiv invests in Scottish firm Amphista Therapeutics
Apr 07, 2020
FinSMEs
BioMotiv: Amphista Therapeutics Raises $7.5M in Series A Funding
Feb 06, 2020
Contract Pharma
BioMotiv: BioMotiv, BMS Launch Anteros Pharmaceuticals
Feb 05, 2020
Outsourcing-Pharma
BioMotiv: Charles River-backed BioMotiv bears fruit with first biotech
Feb 05, 2020
pharmaphorum
BioMotiv: BMS, BioMotiv alliance generates biopharma company Anteros
Feb 04, 2020
Xconomy
BioMotiv: Bristol-Myers, BioMotiv Pact Leads to a New Fibrosis-Focused Startup
BioMotiv Competitors
1
2
3
4
5
6
7
8
9
10